{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:38:53Z","timestamp":1779381533491,"version":"3.53.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clon.2024.10.035","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T20:21:38Z","timestamp":1729369298000},"page":"103663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical Outcomes and Relevance of Composite V12 Gy in Patients With Four or More Brain Metastases Treated With Single Fraction Stereotactic Radiosurgery"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-1172","authenticated-orcid":false,"given":"S.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Alluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-7548","authenticated-orcid":false,"given":"F.","family":"Evison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-715X","authenticated-orcid":false,"given":"H.","family":"Benghiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sawlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2998-8919","authenticated-orcid":false,"given":"V.","family":"Wykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.clon.2024.10.035_bib1","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.clon.2024.10.035_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2024.10.035_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial","volume":"316","author":"Brown","year":"2016","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.clon.2024.10.035_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.clon.2024.10.035_bib5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO\u2013ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2024.10.035_bib6","article-title":"Radiotherapy dose fractionation: fourth edition. Brain metastases","year":"2024","journal-title":"Radiother Dose Fraction"},{"issue":"5","key":"10.1016\/j.clon.2024.10.035_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000480666","article-title":"Impact of the Number of Metastatic Tumors Treated by Stereotactic Radiosurgery on the Dose to Normal Brain: Implications for Brain Protection","volume":"95","author":"Rivers","year":"2017","journal-title":"Stereotact Funct Neurosurg"},{"issue":"22","key":"10.1016\/j.clon.2024.10.035_bib8","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.3390\/cancers15225404","article-title":"Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques","volume":"15","author":"Bodensohn","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.clon.2024.10.035_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","article-title":"12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors","volume":"64","author":"Korytko","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2024.10.035_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clon.2024.10.035_bib11","first-page":"373","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors","volume":"123","author":"Sneed","year":"2015","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.10.035_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/sni.sni_303_18","article-title":"Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases","volume":"10","author":"Peng","year":"2019","journal-title":"Surg Neurol Int"},{"issue":"1","key":"10.1016\/j.clon.2024.10.035_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-020-03442-7","article-title":"Neurological outcome and memory performance in patients with 10 or more brain metastases treated with frameless linear accelerator (LINAC)-based stereotactic radiosurgery","volume":"148","author":"Minniti","year":"2020","journal-title":"J\u00a0Neurooncol"},{"issue":"3 Suppl","key":"10.1016\/j.clon.2024.10.035_bib14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2024.10.035_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and Multifraction Stereotactic Radiosurgery Dose\/Volume Tolerances of the Brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2024.10.035_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2024.10.035_bib17","article-title":"Physics Aspects of Quality Control in Radiotherapy (IPEM Report 81)","author":"Patel","year":"2018","journal-title":"Inst Phys Eng Med"},{"issue":"2","key":"10.1016\/j.clon.2024.10.035_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2024.10.035_bib20","unstructured":"Denz R. Visualizing the Causal Effect of a Continuous Variable on a Time-To-Event Outcome. Visualizing the causal effect of a continuous variable on a time-to-event outcome (r-project.org) [accessed 10 December 2023]."},{"issue":"1","key":"10.1016\/j.clon.2024.10.035_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1536867X1701700110","article-title":"The Estimation and Modeling of Cause-specific Cumulative Incidence Functions Using Time-dependent Weights","volume":"17","author":"Lambert","year":"2017","journal-title":"The Stata J"},{"key":"10.1016\/j.clon.2024.10.035_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000001630","article-title":"Visualizing the (Causal) Effect of a Continuous Variable on a Time-To-Event Outcome","volume":"34","author":"Denz","year":"2023","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"1","key":"10.1016\/j.clon.2024.10.035_bib23","article-title":"A\u00a0Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases","volume":"3","author":"Hartgerink","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.clon.2024.10.035_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109744","article-title":"Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized controlled trial","volume":"186","author":"Bodensohn","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2024.10.035_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijrobp.2005.08.035","article-title":"Stereotactic radiosurgery for four or more intracranial metastases","volume":"64","author":"Bhatnagar","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"10.1016\/j.clon.2024.10.035_bib26","first-page":"5","article-title":"Role of Gamma Knife surgery in patients with 5 or more brain metastases","volume":"117","author":"Mohammadi","year":"2012","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.clon.2024.10.035_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/COC.0b013e31825494ef","article-title":"Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery","volume":"36","author":"Raldow","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2024.10.035_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.rpor.2019.08.001","article-title":"Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer","volume":"24","author":"Tullio","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.clon.2024.10.035_bib29","first-page":"70","article-title":"The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy","volume":"27","author":"Daisne","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2024.10.035_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.854364","article-title":"Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery","volume":"12","author":"Park","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clon.2024.10.035_bib31","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.prro.2017.12.011","article-title":"Stereotactic radiosurgery for multiple brain metastases: Results of multicenter benchmark planning studies","volume":"8","author":"Eaton","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.clon.2024.10.035_bib32","article-title":"Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study","volume":"6","author":"Kim","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clon.2024.10.035_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2021.09.007","article-title":"Practical Considerations for Single Isocenter LINAC Radiosurgery of Multiple Brain Metastases","volume":"12","author":"Meeks","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clon.2024.10.035_bib34","first-page":"5","article-title":"Stereotactic Radiosurgery for Brain Metastases: Review of Existing Data and Future Directions","volume":"12","author":"Rahimy","year":"2023","journal-title":"Appl Rad Oncol"},{"issue":"2","key":"10.1016\/j.clon.2024.10.035_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00520-019-05136-x","article-title":"Health-related quality of life in adult patients with brain metastases after stereotactic radiosurgery: a systematic, narrative review","volume":"28","author":"Verhaak","year":"2020","journal-title":"Support Care Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.clon.2024.10.035_bib36","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.21037\/apm.2017.06.11","article-title":"Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases","volume":"6","author":"Zeng","year":"2017","journal-title":"Ann Palliat Med"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:36:25Z","timestamp":1737318985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655524004485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S0936655524004485"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.10.035","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes and Relevance of Composite V12 Gy in Patients With Four or More Brain Metastases Treated With Single Fraction Stereotactic Radiosurgery","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103663"}}